StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · QNTM·Healthcare

Quantum BioPharma Ltd. Stock Analysis & AI Score

Quantum BioPharma Ltd. (QNTM) has an ST Score of 41.8 (C), driven by its Growth (A+) and held back by its Financial Strength (D-). QNTM last traded at $4.00.

Market Closed
$4.00
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
42
ST Score
41.8/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

QNTM
41.8out of 100
Grade C

Quantum BioPharma Ltd. (QNTM) has an ST Score of 41.8 (C), driven by its Growth (A+) and held back by its Financial Strength (D-). QNTM last traded at $4.00.

Strongest
GrowthA+
Weakest
Financial StrengthD-
All factor grades
  • GrowthA+
  • ValuationB-
  • MomentumB-
  • ProfitabilityD+
  • Financial StrengthD-
  • Piotroski2/9
Score methodology
Press Releases

Contact

QNTM stock: frequently asked questions

What is QNTM's ST Score?

Quantum BioPharma Ltd. (QNTM) has an ST Score of 41.8 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is QNTM a buy, hold, or sell?

Our ST Score grades it C (41.8/100). The ST Score is a data-driven signal, not a recommendation.

What are QNTM's factor grades?

Valuation B-, Profitability D+, Financial Strength D-, Momentum B-, Growth A+.

What is QNTM's valuation grade?

Quantum BioPharma Ltd. (QNTM) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is QNTM's growth grade?

Quantum BioPharma Ltd. (QNTM) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is QNTM's profitability grade?

Quantum BioPharma Ltd. (QNTM) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is QNTM's financial strength grade?

Quantum BioPharma Ltd. (QNTM) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is QNTM's Piotroski score?

Quantum BioPharma Ltd. (QNTM) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.